Immunology 2019

OriGene is excited to be one of the exhibitors at this year's Immunology meeting in San Diego, California from May 10 to 12. With over 2 million off-the-shelf products, we are here to support your IO research.

What are we doing at the booth?

This year, we have lots of fun and cool giveaways. Stop by booth #609 and get yours.

Try our high quality antibodies with low risk!

OriGene offers more than 25,000 monoclonal antibodies with high specificity and sensitivity. We use advanced technologies to generate better antigens and validate antibodies through multiple applications and protein samples. For a limited time only, you can request a free antibody sample on our selected antibodies list. These 10 antibodies are all hot-selling cancer biomarkers and IO targets.

What products do we offer?

Download our product brochures and find out how we can help you advance your cancer research.

Flyers

CD19

CTLA4

HER2

IDO1

LOX

CRISPR

Protein

mAb Development

Lenti

cDNA Clones

RNAi

Tissues

Flow Abs for IO Targets

PD-1 UltraMAB

PD-L1 TrueRAB

Cytokines

CD Markers

The Power of Protein Campaign

This year, we are emphasizing on the advantages of proteins made from human cells due to the optimal preservation of protein structure and post-translational modifications, which presumably keep the function of the protein. These proteins are ideal for drug discovery, antibody production, positive controls, assay development, and protein to protein interaction study. You may learn more about our protein portfolio.

To share the power or protein with you, we will introduce various fun activities and giveaways throughout the year. Click here for details.

CellPress Webinar (Sponsored by OriGene)

The Immunotherapy Revolution: Towards Future Cancer Treatments

The discovery and development of immune checkpoint inhibitors has revolutionized the treatment of certain cancers, with the 2018 Nobel Prize in medicine/physiology recognizing these therapies as a "landmark in our fight against cancer." Yet, despite these advances, putative biomarker identification, efficacy, and drug resistance still pose significant therapeutic challenges. In this webinar, leaders in immuno-oncology — Elaine Mardis (The Ohio State University) and Jedd Wolchok (Memorial Sloan Kettering Cancer Center) — survey the landscape of research, revealing new approaches for harnessing the potential of this transformative therapeutic. Watch and download the video below.

See you at booth #609 in San Diego!